FDA — authorised 5 December 2017
- Marketing authorisation holder: NOVO NORDISK INC
- Status: approved
FDA authorised Ozempic on 5 December 2017
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 5 December 2017.
NOVO NORDISK INC holds the US marketing authorisation.